Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this case study, researchers reported the first documented instance of malignant transformation of congenital triangular alopecia into basal cell carcinoma in a 48-year-old woman, underscoring the importance of assessing long-standing alopecic areas for malignancy.

This article discusses the similarities between alopecia areata and Indralupta in Ayurveda and reports no new clinical results, highlighting traditional and modern management approaches for the condition.

This study found that using planimetric surface area measurement might be a useful supplementary method to improve the accuracy of SALT scoring in alopecia areata, particularly for scores S1 to S3.

This case study presents a reversal of hair loss in discoid lupus erythematosus using newer treatments like injectable platelet-rich fibrin.

In this report, a case of an 11-year-old girl with sudden alopecia areata experienced significant hair regrowth after systemic immunosuppressants treatment over three months, highlighting the importance of early diagnosis and personalized management in pediatric cases.

This case series reports the specific dermoscopic features observed in two patients with syphilitic alopecia, highlighting alopecic patches with empty hair follicles and other distinguishing characteristics that may aid in differentiating it from other hair disorders.

This study presents an algorithm that may help physicians diagnose female hair loss by synthesizing patient history, clinical examination, and various diagnostic tests.

This resource outlines the focus areas of the Madridge Journal of Dermatology & Research and reports no new clinical findings.

This case report describes a patient with psoriasis who developed alopecia with unique histological features after anti-TNF therapy, suggesting that such effects may require considering treatment suspension for severe cases.

This study found that RCM combined with dermoscopy can differentiate disease states between alopecia areata, tinea capitis, nevus sebaceous, and linear scleroderma of the scalp by identifying distinct dermal and follicular patterns.

In this case report, a 53-year-old woman with Little-Graham-Piccardi-Lassueur-Syndrome responded well to a treatment regimen of hydroxychloroquine, methotrexate, and other therapies, effectively halting the progression of this rare dermatosis characterized by alopecia and hyperkeratotic eruptions.

This case series reports on three school-aged children developing alopecia areata shortly after COVID-19 infection, suggesting a potential association between the virus and this autoimmune hair loss condition.

This study found that the 308-nm Excimer laser was effective and safe for treating patchy alopecia areata in children, with hair regrowth observed in 60% of treated scalp patches.

The authors concluded that some patients clinically diagnosed with telogen effluvium may actually have alopecia areata incognita, suggested by the presence of dystrophic hairs and development of alopecia patches.

In this study, researchers examined the under-studied mechanisms behind specific dermatological phenomena such as co-localization, Wolf's isotopic phenomenon, Koebner's isomorphic phenomenon, and the recently described Renbök phenomenon, noting that only a few cases have been reported so far.

This study observed a strong negative association between the HLA-DQB1*0201 allele and the alopecia totalis/alopecia universalis phenotype in Caucasian individuals, indicating a potential protective role.

This study observed that alopecia areata in children often presents as mild scalp patches, with the majority showing some hair regrowth following treatment, particularly when using potent topical steroids, which were most commonly prescribed in the reviewed cases.

In this clinical trial, adding topical calcipotriol to intralesional triamcinolone acetonide significantly increased hair regrowth efficacy in scalp alopecia areata patches compared to steroids alone, but not in beard patches, with a lower incidence of atrophy observed.

This study found that intradermal minoxidil 5% alone and with intralesional triamcinolone acetonide significantly reduced alopecia areata dermoscopic findings, while standard intralesional corticosteroids remain the main first-line treatment for patchy alopecia with less than 50% scalp involvement.

In this study, researchers observed a dose-dependent occurrence of persistent radiation-induced alopecia in patients with primary CNS tumors or head and neck sarcomas, noting distinctive patterns and features, and suggesting potential benefits of topical minoxidil and procedural interventions for treatment.

This study found that 88% phenol treatment significantly improved texture, pigmentation, and density of hair regrowth in alopecia areata patients over nine weeks, with 78% showing a good to excellent response.

This case study describes a 64-year-old woman with sarcoidosis who experienced scalp alopecia and hypopigmented patches, which improved with topical clobetasol propionate.

This case study suggests that Ayurvedic treatment, including Karanj oil, herbal churna, and leech therapy, provided significant hair regrowth in a 16-year-old with alopecia areata after three months, despite previous unsuccessful conventional medicine treatments.

In this clinical trial, the authors observed that Dravanti beeja lepa may be safe and effective for promoting hair regrowth in patients with Indralupta (Alopecia Areata).

This study reviews the use of trichoscopy in diagnosing and monitoring alopecia areata, highlighting that certain trichoscopic findings like yellow and black dots, exclamation mark hairs, and others, provide valuable insights into disease status and treatment response.

This study found that a microneedle patch containing tofacitinib-loaded nanoparticles significantly increased hair follicle numbers and promoted hair regeneration with less drug compared to daily topical tofacitinib, suggesting it may be an effective strategy for alopecia treatment by reducing dosing frequency and enhancing drug delivery.

This study tested a hydrogel microneedle patch delivering T reg attractants in mice with alopecia, finding it boosted regulatory T cell numbers at the site, leading to hair regrowth without causing peripheral immunosuppression, suggesting a potential new approach for autoimmune skin disease treatment.

This study reported complete clinical clearance of tinea capitis in a 3-year-old boy after 8 weeks of treatment with oral griseofulvin and ketoconazole shampoo.

This study found that a bioorthogonal microneedle patch delivering AAV-aFGF effectively improved hair follicle regeneration and sustained hair growth in murine alopecia models compared to other methods.

In this study conducted at a tertiary care hospital, the researchers observed that alopecia areata was more prevalent in males aged 21-30, typically presenting as single patches, with anemia being the most common associated systemic condition and lichen planus the most associated dermatological condition.